Fraud, waste, and abuse (FWA) schemes involving diagnostic testing continue to evolve, often leveraging complex coverage rules and aggressive outreach practices. Colon cancer screening kits, while clinically valuable when used appropriately, have increasingly appeared in investigations tied to excessive billing, insufficient documentation, and ques...